Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Jorveza (budesonide)

Indications: Eosinophilic esophagitis, adults.

Call For Patient Input: September 3, 2019

Patient Input Closed: October 23, 2019

Mayzent (siponimod)

Indications: Multiple sclerosis

Call For Patient Input: August 28, 2019

Patient Input Closed: October 18, 2019

TBC (brolucizumab)

Indications: Macular degeneration, age-related

Call For Patient Input: August 28, 2019

Patient Input Closed: October 18, 2019

TBC (etonogestrel)

Indications: Prevention of pregnancy

Call For Patient Input: August 16, 2019

Patient Input Closed: October 7, 2019

Cablivi (caplacizumab)

Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

Call For Patient Input: August 15, 2019

Patient Input Closed: October 4, 2019

Taltz (ixekizumab)

Indications: Ankylosing spondylitis

Call For Patient Input: August 1, 2019

Patient Input Closed: September 23, 2019